PMID- 34487472
OWN - NLM
STAT- MEDLINE
DCOM- 20211011
LR  - 20240118
IS  - 1362-301X (Electronic)
IS  - 0269-9052 (Print)
IS  - 0269-9052 (Linking)
VI  - 35
IP  - 10
DP  - 2021 Aug 24
TI  - Measuring psychological flexibility and cognitive defusion in individuals with 
      acquired brain injury.
PG  - 1301-1307
LID - 10.1080/02699052.2021.1972155 [doi]
AB  - PURPOSE: Acceptance and Commitment Therapy (ACT) is used increasingly for 
      individuals with psychological distress following acquired brain injury (ABI) in 
      different countries. However, questionnaires measuring ACT-processes are often 
      not validated for this patient group and need cross-cultural validation. This 
      study investigated the psychometric properties of the Acceptance and Action 
      Questionnaire for Acquired Brain Injury (AAQ-ABI; measuring psychological 
      flexibility related to thoughts and feelings about ABI) and the Cognitive Fusion 
      Questionnaire (CFQ-7; measuring cognitive defusion). MATERIALS AND METHODS: Score 
      distribution, reliability, and convergent validity of the AAQ-ABI and the CFQ-7 
      were examined in Dutch individuals with ABI. RESULTS: Seventy-three patients with 
      ABI were included. The AAQ-ABI showed good reliability (Cronbach's alpha = 0.87) and 
      the CFQ-7 excellent reliability (Cronbach's alpha = 0.97). Both did not show a floor 
      or ceiling effect, nor a skewed distribution. There were strong to moderate 
      correlations between the questionnaires and measures of psychological 
      flexibility, mood, quality of life, and value-driven behavior (AAQ-ABI: r 
      = -0.70-0.81; CFQ-7 = -0.67-0.84). Inter-item total correlations indicate that 
      the questions within each questionnaire measured the same construct (AAQ-ABI: r 
      = 0.40-0.78; CFQ-7: r = 0.84-0.93). CONCLUSIONS: The current study shows that the 
      Dutch AAQ-ABI and CFQ-7 have acceptable to good psychometric properties when 
      measuring psychological flexibility and cognitive defusion in patients with ABI.
FAU - Rauwenhoff, Johanne
AU  - Rauwenhoff J
AUID- ORCID: 0000-0002-0064-6560
AD  - Limburg Brain Injury Centre, Maastricht, The Netherlands.
AD  - Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and 
      Neuroscience, Maastricht University, Maastricht, The Netherlands.
FAU - Peeters, Frenk
AU  - Peeters F
AD  - Department of Clinical Psychological Science, Faculty of Psychology and 
      Neuroscience, Maastricht University, Maastricht, The Netherlands.
FAU - Bol, Yvonne
AU  - Bol Y
AD  - Department of Clinical and Medical Psychology, Zuyderland Medical Centre, 
      Sittard-Geleen/Heerlen, The Netherlands.
FAU - Van Heugten, Caroline
AU  - Van Heugten C
AUID- ORCID: 0000-0003-4272-7315
AD  - Limburg Brain Injury Centre, Maastricht, The Netherlands.
AD  - Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and 
      Neuroscience, Maastricht University, Maastricht, The Netherlands.
AD  - School for Mental Health and Neuroscience, Department of Psychiatry and 
      Psychology, Maastricht University, Maastricht University Medical Centre, 
      Maastricht, The Netherlands.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20210906
PL  - England
TA  - Brain Inj
JT  - Brain injury
JID - 8710358
SB  - IM
MH  - *Acceptance and Commitment Therapy
MH  - *Brain Injuries/complications
MH  - Cognition
MH  - Humans
MH  - Psychometrics
MH  - Quality of Life
MH  - Reproducibility of Results
MH  - Surveys and Questionnaires
PMC - PMC10791065
OTO - NOTNLM
OT  - acceptance and commitment therapy
OT  - acquired brain injury
OT  - cognitive defusion
OT  - psychological flexibility
COIS- No authors declare a conflict of interest.
EDAT- 2021/09/07 06:00
MHDA- 2021/10/12 06:00
PMCR- 2021/09/06
CRDT- 2021/09/06 17:06
PHST- 2021/09/07 06:00 [pubmed]
PHST- 2021/10/12 06:00 [medline]
PHST- 2021/09/06 17:06 [entrez]
PHST- 2021/09/06 00:00 [pmc-release]
AID - 1972155 [pii]
AID - 10.1080/02699052.2021.1972155 [doi]
PST - ppublish
SO  - Brain Inj. 2021 Aug 24;35(10):1301-1307. doi: 10.1080/02699052.2021.1972155. Epub 
      2021 Sep 6.